MSK's Physician Relations Lecture Series: 2023 Updates on Lung Cancer

Wednesday, November 15, 2023, 7:30 AM - 8:30 AM, Online

MSK's Physician Relations Team invites you to a complimentary one-hour, virtual update on lung cancer. This complimentary lecture series, hosted by MSK's Physician Relations Team and led by MSK faculty experts, aims to provide valuable updates and insights across a wide range of topics.

In the 2023 Updates on Lung Cancer session:

• Dr. Katherine Gray, MSK Thoracic Surgeon, will provide an update on Resectable Lung Cancer 
• Dr. Michael Hwang, MSK Thoracic Oncologist, will provide an update on Targeted Therapy for Lung Cancer 
• Dr. Daniel Gomez, MSK Radiation Oncologist, will provide an update on The Evolving Role of Radiation Therapy in the Context of Unresectable Lung Cancer: Where Are We Now and Where Are We Going?

Lectures will be followed by a Q&A session with the speakers, providing attendees the opportunity to engage with the faculty and ask questions. Additionally, attendees will receive access to an online syllabus after the meeting concludes, which includes select PDFs of the faculty presentations (slides) and recorded videos. Please note that you must check in during the meeting in order to receive access to the syllabus.

This session will be delivered virtually (via Zoom) and is intended for physicians, surgeons, APPs, nurses, trainees, and other healthcare professionals interested in lung cancer.

1. State updated screening guidelines for lung cancer
2. Recognize the indications for lobar vs sublobar resections for lung cancer
3. Describe updates to multimodal treatment modalities, including immunotherapy in resectable lung cancer
4. Discuss the next generation sequencing
5. Recognize frontline options in stage IV disease
6. Identify treatment options in early stage or locally advanced disease
7. Describe standard of care treatment options in the context of unresectable lung cancer
8. Discuss ongoing trials examining the role of radiation therapy in the context of unresectable lung cancer

Registration is complimentary*. Please sign up through the 'Register' tab at the top of the page. Detailed access and participation instructions, including a Zoom link, can be accessed in the conformation email you will receive once registration is complete.

If you register for this program and are no longer able to attend, we do ask that you notify [email protected].

MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, you will be notified via email from MSK CME ([email protected]). MSK CME is not responsible for any related costs, charges, or expenses to participants.

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Katherine Gray, MD
Thoracic Surgeon

Michael Hwang, MD
Thoracic Oncologist

Daniel Gomez, MD, MBA
Radiation Oncologist

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

Wednesday, November 15, 2023